Replay available

Cara Therapeutics, Inc. (CARA) Q3 2022 Earnings Call

Cara Therapeutics, Inc. (NASDAQ: CARA) Q3 2022 earnings conference call, held 2022-11-07. Replay captured from the company's public earnings webcast.

Mon, November 7, 2022 at 4:30 PMendedReplay
Cara Therapeutics, Inc. (CARA) Q3 2022 Earnings Call

Hosted by

Featured presenters

Matt Murphy

Manager of Investor Relations

Chris Posner

Chief Executive Officer

Ryan Maynard

Chief Financial Officer

Sumant Kokani

Analyst, Canaccord Genuity

Joseph Stringer

Analyst, Needham & Company

Daniel Wally

Analyst, JP Morgan

Stacy Lee

Analyst, C4

David Amselin

Analyst, Piper Sandler

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tvardi Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.293 Good afternoon. My name is Shannon, and I will be your conference facilitator. 00:00:04.293 -- 00:00:08.636 I would like to welcome everyone to the Carer Therapeutics third quarter 2022 financial 00:00:08.636 -- 00:00:12.840 results and update conference call. All lines have been placed on mute to avoid any background 00:00:12.840 -- 00:00:17.084 noise. After the speaker's remarks, there will be a question and answer session. 00:00:17.084 -- 00:00:20.236 If you would like to ask a question during this time, simply press star and the number 00:00:20.236 -- 00:00:25.271 11 on your telephone keypad. Please be advised that this call is being 00:00:25.271 -- 00:00:30.031 recorded. I'll now like to introduce Matt Murphy, CARA's Manager of Investor Relations. 00:00:30.031 -- 00:00:33.112 Mr. Murphy, you may begin your call. 00:00:33.474 -- 00:00:38.478 Thank you, operator, and good afternoon. Just after market closed today, CARA issued 00:00:38.478 -- 00:00:44.163 a news release announcing the company's results for the third quarter of 2022. 00:00:44.163 -- 00:00:48.686 Copies of this news release and SEC filings can be found in the investor section of our 00:00:48.686 -- 00:00:52.028 website at www.caratherapeutics.com. 00:00:53.769 -- 00:00:57.151 Before we begin, I would like to remind you that during the course of this conference 00:00:57.151 -- 00:01:02.095 call, we will be making certain forward-looking statements about CARA and our programs 00:01:02.095 -- 00:01:05.437 based on management's current plans and expectations. 00:01:05.437 -- 00:01:09.350 These statements are being made under the Private Securities Litigation Reform Act of 00:01:09.350 -- 00:01:11.001 1995, 00:01:11.001 -- 00:01:14.504 and they are subject to various ri...